Share：
Share this content in WeChat
X
[Chinese][PDF]80877
• Review •
Application progress of radiomics in cervical cancer
CUI Yaqiong  WANG Lili  ZHAO Lianping  HUANG Gang 

Cite this article as: Cui YQ, Wang LL, Zhao LP, et al. Application progress of radiomics in cervical cancer. Chin J Magn Reson Imaging, 2020, 11(6): 477-480. DOI:10.12015/issn.1674-8034.2020.06.020.


[Abstract] The incidence and mortality of cervical cancer are high and increasing, the age of onset was significantly younger, therefore, early diagnosis and treatment become particularly important. The treatment depends on the clinical stage, and the prognosis of patients with the same clinicopathological characteristics are quite different. Radiomics can improve the diagnosis and prognosis of cervical cancer owing to its characteristics of noninvasive, quantitative, rapid, dynamic and repeatable, and help clinicians in making decisions. This paper will review the process of radiomics, the application status and development prospect of radiomics in cervical cancer.
[Keywords] radiomics；uterine cervical neoplasms；magnetic resonance imaging

CUI Yaqiong Gansu University of Chinese Medicine, Lanzhou 730000, China; Department of Radiology, Gansu Province Hospital, Lanzhou 730000, China

WANG Lili Department of Radiology, Gansu Province Hospital, Lanzhou 730000, China

ZHAO Lianping Department of Radiology, Gansu Province Hospital, Lanzhou 730000, China

HUANG Gang* Department of Radiology, Gansu Province Hospital, Lanzhou 730000, China

*Corresponding to: Huang G, E-mail: keen0999@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of Research Fund for Internal Medicine of Gansu People's Hospital No. 16GSSY1-7
Received  2020-02-18
Accepted  2020-04-12
DOI: 10.12015/issn.1674-8034.2020.06.020
Cite this article as: Cui YQ, Wang LL, Zhao LP, et al. Application progress of radiomics in cervical cancer. Chin J Magn Reson Imaging, 2020, 11(6): 477-480. DOI:10.12015/issn.1674-8034.2020.06.020.

[1]
Small WJ, Bacon MA, Bajaj A, et al. Cervical cancer: A global health crisis. Cancer, 2017, 123(13): 2404-2412.
[2]
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin, 2018, 68(6): 394-424.
[3]
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA: A Cancer J Clin, 2016, 66(2): 115-132.
[4]
Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine neoplasms, version 1.2018, nccn clinical practice guidelines in oncology. J National Comprehensive Cancer Network Jnccn, 2018, 16(2): 170-199.
[5]
Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer, 2012, 48(4): 441-446.
[6]
Mackin D, Fave X, Zhang L, et al. Measuring computed tomography scanner variability of radiomics features. Invest Radiol, 2015, 50(11): 757.
[7]
Lin YC, Lin CH, Lu HY, et al. Deep learning for fully automated tumor segmentation and extraction of magnetic resonance radiomics features in cervical cancer. Eur Radiol, 2020, 30(3): 1297-1305.
[8]
Mu W, Chen Z, Shen W, et al. A segmentation algorithm for quantitative analysis of heterogeneous tumors of the cervix with (1)(8)f-fdg pet/ct. IEEE Trans Biomed Eng, 2015, 62(10): 2465-2479.
[9]
李双双，侯震，刘娟,等．影像组学分析与建模工具综述．中国医学物理学杂志, 2018, 35(9): 1043-1049.
[10]
Rahmim A, Schmidtlein CR, Jackson A, et al. A novel metric for quantification of homogeneous and heterogeneous tumors in pet for enhanced clinical outcome prediction. Physics in Medicine & Biology, 2016, 61(1): 227-242.
[11]
吴亚平，林予松，顾建钦，等．影像组学的研究进展与挑战．中华放射学杂志, 2017, 51(12): 983-985.
[12]
Akita A, Shinmoto H, Hayashi S, et al. Comparison of T2-weighted and contrast-enhanced T1-weighted MR imaging at 1.5 T for assessing the local extent of cervical carcinoma. Eur Radiol, 2011, 21(9): 1850.
[13]
Kuang F, Yan Z, Li H, et al. Diagnostic accuracy of diffusion-weighted mri for differentiation of cervical cancer and benign cervical lesions at 3.0 T: Comparison with routine MRI and dynamic contrast-enhanced MRI. J Magne Reson Imaging, 2015, 42(4): 1094-1099.
[14]
Moro F, Gui B, Arciuolo D, et al. Fusion imaging of ultrasound and mri in the assessment of locally advanced cervical cancer: A prospective study. Int J Gynecol Cancer, 2020, 30(4): 456-465.
[15]
Lin Y, Li H, Chen Z, et al. Correlation of histogram analysis of apparent diffusion coefficient with uterine cervical pathologic finding. Am J Roentgenol, 2015, 204(5): 1125-1131.
[16]
Guan Y, Li W, Jiang Z, et al. Whole-lesion apparent diffusion coefficient-based entropy-related parameters for characterizing cervical cancers. Acad Radiol, 2016, 23(12): 1559-1567.
[17]
Lu Y, Peng W, Song J, et al. On the potential use of dynamic contrast-enhanced (dce) MRI parameters as radiomic features of cervical cancer. Med Phys, 2019, 46(11): 5098-5109.
[18]
Wang X, Lin W, Mao Y, et al. A comparative study of two-compartment exchange models for dynamic contrast-enhanced MRI in characterizing uterine cervical carcinoma. Contrast Media Molecular Imaging, 2019, 2019: 3168416.
[19]
Shao J, Zhang Z, Liu H, et al. Dce-mri pharmacokinetic parameter maps for cervical carcinoma prediction. Comput Biol Med, 2020, 118: 103634.
[20]
Downey K, Riches SF, Morgan VA, et al. Relationship between imaging biomarkers of stage i cervical cancer and poor-prognosis histologic features: Quantitative histogram analysis of diffusion-weighted mr images. AJR Am J Roentgenol, 2013, 200(2): 314-320.
[21]
Tsujikawa T, Rahman T, Yamamoto M, et al. (18)f-fdg pet radiomics approaches: Comparing and clustering features in cervical cancer. Ann Nucl Med, 2017, 31(9): 678-685.
[22]
Shen WC, Chen SW, Liang JA, et al. [18]Fluorodeoxyglucose positron emission tomography for the textural features of cervical cancer associated with lymph node metastasis and histological type. Eur J Nucl Med Mol Imaging, 2017, 44(10): 1721-1731.
[23]
Liu Y, Zhang Y, Cheng R, et al. Radiomics analysis of apparent diffusion coefficient in cervical cancer: A preliminary study on histological grade evaluation. J Magne Reson Imaging, 2019, 49(1): 280-290.
[24]
Mu W, Chen Z, Liang Y, et al. Staging of cervical cancer based on tumor heterogeneity characterized by texture features on 18f-fdg pet images. Physics in Med Biology, 2015, 60(13): 5123.
[25]
Becker AS, Ghafoor S, Marcon M, et al. Mri texture features may predict differentiation and nodal stage of cervical cancer: A pilot study. Acta Radiol Open, 2017, 6(10): 2058.
[26]
Wu Q, Shi D, Dou S, et al. Radiomics analysis of multiparametric mri evaluates the pathological features of cervical squamous cell carcinoma. J Magn Reson Imaging, 2019, 49(4): 1141-1148.
[27]
Halle C, Andersen E, Lando M, et al. Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced mri. Cancer Res, 2012, 72(20): 5285-5295.
[28]
Andersen EK, Hole KH, Lund KV, et al. Pharmacokinetic parameters derived from dynamic contrast enhanced mri of cervical cancers predict chemoradiotherapy outcome. Radiother Oncol, 2013, 107(1): 117-122.
[29]
Li K, Sun H, Lu Z, et al. Value of [18f] fdg pet radiomic features and vegf expression in predicting pelvic lymphatic metastasis and their potential relationship in early-stage cervical squamous cell carcinoma. Eur J Radiol, 2018, 106: 160-166.
[30]
Meyer HJ, Hamerla G, Höhn AK, et al. Whole lesion histogram analysis derived from morphological mri sequences might be able to predict egfr-and her2-expression in cervical cancer. Acad Radiol, 2019, 26(8): e208-e215.
[31]
Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri. Int J Gynecol Obstetrics, 2018, 143(S2): 22-36.
[32]
Carlson RW, Scavone JL, Koh WJ, et al. Nccn framework for resource stratification: A framework for providing and improving global quality oncology care. J National Comprehensive Cancer Network, 2016, 14(8): 961-969.
[33]
Yu YY, Zhang R, Dong RT, et al. Feasibility of an adc-based radiomics model for predicting pelvic lymph node metastases in patients with stage ib-iia cervical squamous cell carcinoma. Br J Radiol, 2019, 92(1097): 20180986.
[34]
Wu Q, Wang S, Chen X, et al. Radiomics analysis of magnetic resonance imaging improves diagnostic performance of lymph node metastasis in patients with cervical cancer. Radiother Oncol, 2019, 138: 141-148.
[35]
Chen J, He B, Dong D, et al. Noninvasive ct radiomic model for preoperative prediction of lymph node metastasis in early cervical carcinoma. British J Radiol, 2020, 93(1108): 20190558.
[36]
Jin X, Ai Y, Zhang J, et al. Noninvasive prediction of lymph node status for patients with early-stage cervical cancer based on radiomics features from ultrasound images. Eur Radiol, 2020, 1-8. DOI: org/10.1007/s00330-020-06692-1.
[37]
Luo L, Luo Q, Tang L. Diagnostic value and clinical significance of mri and ct in detecting lymph node metastasis of early cervical cancer. Oncology Letters, 2020, 19(1): 700-706.
[38]
Li Z, Li H, Wang S, et al. Mr-based radiomics nomogram of cervical cancer in prediction of the lymph-vascular space invasion preoperatively. J Magn Reson Imaging, 2019, 49(5): 1420-1426.
[39]
Wang S, Chen X, Liu Z, et al. Radiomics analysis on T2-mr image to predict lymphovascular space invasion in cervical cancer. Medical Imaging 2019: Computer-Aided Diagnosis, International Society for Optics and Photonics, 2019, 10950: 1095040. DOI: org/10.1117/12.2513129.
[40]
Hua W, Xiao T, Jiang X, et al. Lymph-vascular space invasion prediction in cervical cancer: Exploring radiomics and deep learning multilevel features of tumor and peritumor tissue on multiparametric MRI. Biomedical Signal Processing and Control, 2020, 58: 101869.
[41]
Altazi B, Fernandez D, Zhang G, et al. Suej-258: Prediction of cervical cancer treatment response using radiomics features based on f18-fdg uptake in pet images. Med Phys, 2015, 42(6Part11): 3326-3326.
[42]
Altazi BA, Fernandez DC, Zhang GG, et al. Investigating multi-radiomic models for enhancing prediction power of cervical cancer treatment outcomes. Phys Med, 2018, 46: 180-188.
[43]
Sun C, Tian X, Liu Z, et al. Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study. EBio Med, 2019, 46: 160-169.
[44]
Tian X, Sun C, Liu Z, et al. Prediction of response to preoperative neoadjuvant chemotherapy in locally advanced cervical cancer using multicenter ct-based radiomic analysis. Front in Oncol, 2020, 10: 77.
[45]
Reuze S, Orlhac F, Nioche C, et al. Prediction of cervical cancer recurrence using textural features calculated from 18f-fdg pet images. J Nuclear Med, 2016, 57(Suppl 2): 422-423.
[46]
Chen SW, Shen WC, Hsieh TC, et al. Textural features of cervical cancers on fdg-pet/ct associate with survival and local relapse in patients treated with definitive chemoradiotherapy. Sci Rep, 2018, 8(1): 11859.
[47]
Hao H, Zhou Z, Li S, et al. Shell feature: A new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer. Phys Med Biol, 2018, 63(9): 95007.
[48]
Lucia F, Visvikis D, Vallieres M, et al. External validation of a combined pet and mri radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging, 2019, 46(4): 864-877.
[49]
Lucia F, Visvikis D, Desseroit MC, et al. Prediction of outcome using pretreatment 18 f-fdg pet/ct and mri radiomics in locally advanced cervical cancer treated with chemoradiotherapy. Eur J Nuclear Med Mol Imaging, 2018, 45(5): 768-786.
[50]
Kan Y, Dong D, Zhang Y, et al. Radiomic signature as a predictive factor for lymph node metastasis in early-stage cervical cancer. J Magne Reson Imaging, 2019, 49(1): 304-310.
[51]
Altazi BA, Zhang GG, Fernandez DC, et al. Reproducibility of f18-fdg pet radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms. J Appl Clin Med Phys, 2017, 18(6): 32-48.
[52]
Reuzé S, Orlhac F, Chargari C, et al. Prediction of cervical cancer recurrence using textural features extracted from 18f-fdg pet images acquired with different scanners. Oncotarget, 2017, 8(26): 43169.
[53]
Traverso A, Wee L, Dekker A, et al. Repeatability and reproducibility of radiomic features: A systematic review. Int J Radiat Oncol Biol Phys, 2018, 102(4): 1143-1158.
[54]
Fiset S, Welch ML, Weiss J, et al. Repeatability and reproducibility of mri-based radiomic features in cervical cancer. Radiother Oncol, 2019, 135: 107-114.
[55]
Brooks FJ, Grigsby PW. Fdg uptake heterogeneity in figo iib cervical carcinoma does not predict pelvic lymph node involvement. Radiation Oncology, 2013, 8(1): 294.

PREV Research progress in the diagnosis and treatment of tumors by magnetic iron oxide nanoparticles with chemotherapeutics
NEXT Predicting the histological classification of cervical squamous cell carcinoma based on multi-sequence MRI radiomics model
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn